Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal thyroid disorders.

Annette Grüters1, Heike Biebermann, Heiko Krude

  • 1Department of Paediatric Endocrinology, Charité Children's Hospital, Humboldt University, Berlin, Germany. annette.grueters@charite.de

Hormone Research
|February 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Germany's national genomDE strategy.

Nature medicine·2025
Same author

MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor.

Nature communications·2025
Same author

Author Correction: Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.

Nature genetics·2025
Same author

MCT8 Deficiency in Females.

The Journal of clinical endocrinology and metabolism·2025
Same author

Patients with Allan-Herndon-Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration.

Nature communications·2025

Congenital hypothyroidism, a common newborn endocrine disorder, is treatable with early diagnosis. Recent research clarifies genetic causes, including mutations in thyroid peroxidase, sodium-iodide symporter, pendrin, TSH receptor genes, and transcription factors, improving patient care.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital hypothyroidism (CH) is the most common endocrine disorder in newborns, affecting 1 in 3000-4000 births.
  • Newborn screening and early treatment of CH are highly effective, ensuring normal development in most cases.
  • The underlying genetic causes for CH are increasingly being elucidated, particularly in patients with normal thyroid development or defective thyroid development.

Purpose of the Study:

  • To clarify the molecular basis of congenital hypothyroidism.
  • To identify genetic mutations responsible for different forms of CH.
  • To understand the impact of genetic defects on thyroid and central nervous system (CNS) development and patient outcomes.

Main Methods:

  • Genetic analysis of patients with congenital hypothyroidism.

Related Experiment Videos

  • Identification of loss-of-function mutations in genes such as thyroid peroxidase, sodium-iodide symporter, pendrin, TSH receptor, and transcription factors (e.g., NKX2.1).
  • Investigation of mutations in TSH-beta gene and developmental defects in hypothalamus/pituitary for central hypothyroidism.

    • Main Results:

    • Autosomal recessive mutations in thyroid peroxidase, sodium-iodide symporter, and pendrin genes cause CH with normal thyroid development.
    • Mutations in the TSH receptor and transcription factors are linked to defective thyroid development.
    • NKX2.1 gene defects cause both thyroid and CNS developmental issues, leading to persistent neurological deficits.
    • Central hypothyroidism can result from TSH-beta gene mutations or hypothalamic/pituitary defects, with some cases showing impaired mental development.

    Conclusions:

    • Clarifying molecular defects in CH improves understanding of disease variability and outcomes.
    • Genetic insights enable the development of novel diagnostic and therapeutic strategies for CH.
    • Accurate genetic diagnosis is crucial for effective patient counseling and management of congenital hypothyroidism.